378 related articles for article (PubMed ID: 28370561)
21. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
22. Regulatory effects of microRNA‑184 on osteosarcoma via the Wnt/β‑catenin signaling pathway.
Du Z; Li F; Wang L; Huang H; Xu S
Mol Med Rep; 2018 Aug; 18(2):1917-1924. PubMed ID: 29916553
[TBL] [Abstract][Full Text] [Related]
23. Fermented Oyster Extract Promotes Osteoblast Differentiation by Activating the Wnt/β-Catenin Signaling Pathway, Leading to Bone Formation.
Molagoda IMN; Karunarathne WAHM; Choi YH; Park EK; Jeon YJ; Lee BJ; Kang CH; Kim GY
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31698882
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
25. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway.
Liu X; Geng Z; Ding X; Lou Y; Zhang X
Bioengineered; 2022 May; 13(5):13280-13292. PubMed ID: 35635031
[TBL] [Abstract][Full Text] [Related]
26. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
[TBL] [Abstract][Full Text] [Related]
27. RUNX2 expression in developing human bones and various bone tumors.
Sugawara M; Kato N; Tsuchiya T; Motoyama T
Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
[TBL] [Abstract][Full Text] [Related]
29. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.
Cai T; Sun D; Duan Y; Wen P; Dai C; Yang J; He W
Exp Cell Res; 2016 Jul; 345(2):206-17. PubMed ID: 27321958
[TBL] [Abstract][Full Text] [Related]
30. Myeloma cell-derived Runx2 promotes myeloma progression in bone.
Trotter TN; Li M; Pan Q; Peker D; Rowan PD; Li J; Zhan F; Suva LJ; Javed A; Yang Y
Blood; 2015 Jun; 125(23):3598-608. PubMed ID: 25862559
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
[TBL] [Abstract][Full Text] [Related]
32. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
[TBL] [Abstract][Full Text] [Related]
33. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
34. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
Liu L; Wang R; Zhang Z; Wang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/β-catenin signaling pathway.
Wang Y; Sun S; Xu J; Luo Y; Xin Y; Zhao X
Oncol Rep; 2018 Feb; 39(2):589-596. PubMed ID: 29207112
[TBL] [Abstract][Full Text] [Related]
36. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
Wu BQ; Cao Y; Bi ZG
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
[TBL] [Abstract][Full Text] [Related]
37. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
Kurek KC; Del Mare S; Salah Z; Abdeen S; Sadiq H; Lee SH; Gaudio E; Zanesi N; Jones KB; DeYoung B; Amir G; Gebhardt M; Warman M; Stein GS; Stein JL; Lian JB; Aqeilan RI
Cancer Res; 2010 Jul; 70(13):5577-86. PubMed ID: 20530675
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
[TBL] [Abstract][Full Text] [Related]
39. Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt/β-catenin signal pathway.
Sha L; Ma D; Chen C
Aging (Albany NY); 2020 Dec; 12(23):23598-23608. PubMed ID: 33310972
[TBL] [Abstract][Full Text] [Related]
40. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC
Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]